Abstract
The article describes the benefits of rebamipide and proton pump inhibitors combination therapy for acid-related diseases. It was shown that rebamipide have a positive effect on various parts of the protective barrier of the epithelium in gastroesophageal reflux disease, chronic gastritis, peptic ulcer disease, functional dyspepsia, NSAID-induced gastrointestinal erosive and ulcerative lesions, and in the treatment of Helicobacter pylori infection. Key words: gastroesophageal reflux disease, proton pump inhibitors, NSAID gastropathy, rebamipide, functional dyspepsia, peptic ulcer disease, Helicobacter pylori
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
